A Folate Receptor-targeted Emulsion Formulation for Paclitaxel

Anticancer Research

Volumn 23, Issue 6 C, 2003, Pages 4927-4931

  Stevens, Phillip J ^a   Lee, Robert J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b College of Pharmacy ^*  (United States)

Author keywords

Folate receptor; Paclitaxel; Targeted emulsion

Indexed keywords

CHOLESTEROL; DRUG CARRIER; DRUG RECEPTOR; FOLATE POLYETHYLENEGLYCOL CHOLESTEROL; FOLATE RECEPTOR; OLEIC ACID; PACLITAXEL; PHOSPHATIDYLCHOLINE; POLYETHYLENEGLYCOL DISTEAROYLPHOSPHATIDYLETHANOLAMINE; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG FORMULATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG SYNTHESIS; DRUG TARGETING; EMULSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; INJECTION; LIPOPHILICITY; PARTICLE SIZE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAPSULES; CARRIER PROTEINS; CELL SURVIVAL; DRUG CARRIERS; DRUG STABILITY; EMULSIONS; HUMANS; INJECTIONS; KB CELLS; PACLITAXEL; RECEPTORS, CELL SURFACE;

EID: 0842333184     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Singla AK, Garg A and Aggarwal D: Paclitaxel and its formulations. Int J Pharm 235: 179-192, 2002.
2. Sharma A, Mayhew E, Bolcsak L, Cavanaugh C, Harmon P, Janoff A and Bernacki RJ: Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71: 103-107, 1997.
3. TM (paclitaxel) with phospholipid bilayers. J Biomed Mater Res 46: 141-149, 1999.
4. Kan P, Chen Z, Lee C and Chu I: Development of nonionic surfactant/phospholipid o/w emulsion as a paclitaxel delivery system. J Control Release 58: 271-278, 1999.
5. Constantinides PP, Lambert KJ, Tustian AK, Schneider B, Lalji S, Ma W, Wentzel B, Kessler D, Worah D and Quay SC: Formulation development and antitumor activity of a filter-sterilizable emulsion of paclitaxel. Pharm Res 17: 175-181, 2000.
6. Bissery MC, Guenard D, Guerrite-Voegelein F and Lavelle F: Experimental antitumor activity of taxotere (RP56976, NSC628503) a paclitaxel analogue. Cancer Res 51: 4845, 1991.
7. Tarr BD and Yalkowsky SH: A new parenteral vehicle for the administration of some poorly soluble anti-cancer drugs. J Parentral Sci Technol 41: 31, 1987.
8. Onyuksel HA, Ramakrishnan S, Chai HB and Pezzuto JM: A mixed micellar formulation suitable for the parenteral administration of paclitaxel. Pharm Res 11: 206-212, 1994.
9. Lee JW, Lu JY, Low PS and Fuchs PL: Synthesis and evaluation of paclitaxel-folic acid conjugates as targeted antineoplastics. Bioorganic Medicinal Chem 10: 2397-2414, 2002.
10. Weitman SD, Lark RH, Coney LR, Fort DW, Frasca V, Zurawski VR Jr and Kamen BA: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res 52: 3396-3401, 1992.
11. Garin-Chesa P, Campbell I, Salgo P, Lewis J, Old L and Tettig W: Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Path 142: 557-567, 1993.
12. Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M and Boiocchi M: Overexpression of folate binding protein in ovarian cancers. Int J Cancer 74: 193-198, 1997.
13. Leamon CP and Low PS: Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA 88: 5572-5576, 1991.
14. Guo W, Sudimack J and Lee RJ: Receptor-specific delivery of liposomes via folate-PEG-chol. J Liposome Res 10: 179-195, 2000.
15. Pan XQ, Wang H, Shukla S, Sekido M, Adams DM, Tjarks W, Barth RF and Lee RJ: Boron-containing folate receptor-targeted liposomes as potential delivery agents for neutron capture therapy. Bioconj Chem 13: 435-553, 2002.
16. Sudimack JJ, Adams D, Rotaru J, Shukla S, Yan J, Sekido M, Barth RF, Tjarks W and Lee RJ: Folate receptor-mediated liposomal delivery of a lipophilic boron agent to tumor cells in vitro for neutron capture therapy. Pharm Res 19: 1502-1508, 2002.
17. Lee RJ and Low PS: Folate-mediated tumor cell targeting of liposomes-entrapped doxorubicin in vitro. Biochim Biophysica Acta 1233: 134-144, 1995.
18. Sudimack JJ and Lee RJ: Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41: 147-162, 2000.
19. Gosselin MA and Lee RJ: Folate receptor-targeted liposomes as vectors for therapeutic agents. In: M.R. El-Gewely (ed.) Biotechnology Annual Review, Vol 8, Amsterdam: Elsevier Science, 2002, pp. 103-131.
20. Ali S, Ahmad I, Peters A and Masters G: Hydrolyzable hydrophobic taxanes: synthesis and anti-cancer activities. Anticancer Drugs 12: 117-28, 2001.
21. Ali S, Minchey S, Janoff A and Mayhew E: A differential scanning calorimetry study of phosphocholines mixed with paclitaxel and it bromoacylated taxanes. Biophys J 78: 246-256, 2000.
22. Duncan R, Gac-Breton S, Keane R and Musila R: Polymerdrug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J Control Release 74: 135-146, 2001.
23. Ceruti M, Crosasso P, Brusa P, Arpicco S, Dosio F and Cattel L: Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing water-soluble prodrugs of paclitaxel. J Control Release 63: 141-153, 2000.
24. Folkman J and Greenspan HP: Influence of geometry on control of cell growth. Biochim Biophys Acta 417: 211-236, 1975.
25. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, Jain RK and McDonald DM: Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156: 1363-1380, 2000.
26. Belotti D, Vergani V, Drudis T, Borsotti P, Pitelli MR, Viale G, Giavazzi R and Taraboletti G: The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin Cancer Res 2: 1843-1849, 1996.
27. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD and Jain RK: Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 59: 3776-3782, 1999.